Hong Kong, China vs Jordan: Breast cancer death rate in women
Hong Kong, China
10.32 deaths per 100,000 people
in 2017
Jordan
10.82 deaths per 100,000 people
in 2018
Hong Kong, China rank
86th
Jordan rank
83rd
Breast cancer death rate in women over time
- Hong Kong, China
- Jordan
How they compare
Jordan currently reports 10.82 deaths per 100,000 people against 10.32 deaths per 100,000 people in Hong Kong, China, a difference of 0.5 deaths per 100,000 people.
Across all 8 years both countries report, Jordan has been ahead every year.
Hong Kong, China ranks 86th and Jordan ranks 83rd of 111 countries.
Jordan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Hong Kong, China | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.51 deaths per 100,000 people | 11.6 deaths per 100,000 people | 2.09 deaths per 100,000 people | Jordan |
| 2010s | 9.74 deaths per 100,000 people | 12.24 deaths per 100,000 people | 2.5 deaths per 100,000 people | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher breast cancer death rate in women, Hong Kong, China or Jordan?
- Jordan, at 10.82 deaths per 100,000 people against 10.32 deaths per 100,000 people in Hong Kong, China as of 2018.
- What is the difference in breast cancer death rate in women between Hong Kong, China and Jordan?
- 0.5 deaths per 100,000 people, with Jordan ahead.
- How many years of comparable data are there for Hong Kong, China and Jordan?
- 8 years are reported by both, from 2008 to 2017.
- How do Hong Kong, China and Jordan rank globally for breast cancer death rate in women?
- Hong Kong, China ranks 86th and Jordan ranks 83rd of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Breast cancer death rate in women. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from breast cancer in females in those aged all ages per 100,000 people.